372 related articles for article (PubMed ID: 16606808)
21. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
22. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of genetic testing in adults with a history of venous thromboembolism.
Segal JB; Brotman DJ; Emadi A; Necochea AJ; Samal L; Wilson LM; Crim MT; Bass EB
Evid Rep Technol Assess (Full Rep); 2009 Jun; (180):1-162. PubMed ID: 20629476
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV; Saemundsson Y; Isma N; Gottsäter A; Svensson PJ
Thromb Res; 2012 Sep; 130(3):467-71. PubMed ID: 22512897
[TBL] [Abstract][Full Text] [Related]
25. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
[TBL] [Abstract][Full Text] [Related]
26. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband.
Rossi E; Ciminello A; Za T; Betti S; Leone G; De Stefano V
Thromb Haemost; 2011 Oct; 106(4):646-54. PubMed ID: 21833444
[TBL] [Abstract][Full Text] [Related]
27. Thrombophilia gene mutations predict venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Roy DC; Wang TF; Carrier M; Mallick R; Burger D; Hawken S; Wells PS
J Thromb Haemost; 2023 Nov; 21(11):3184-3192. PubMed ID: 37536569
[TBL] [Abstract][Full Text] [Related]
28. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism.
Bonduel M; Hepner M; Sciuccati G; Pieroni G; Feliú-Torres A; Mardaraz C; Frontroth JP
Thromb Haemost; 2002 Jun; 87(6):972-7. PubMed ID: 12083504
[TBL] [Abstract][Full Text] [Related]
29. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
Genet Med; 2011 Jan; 13(1):67-76. PubMed ID: 21150787
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of screening and extended anticoagulation for carriers of both factor V Leiden and prothrombin G20210A.
Marchetti M; Quaglini S; Barosi G
QJM; 2001 Jul; 94(7):365-72. PubMed ID: 11435632
[TBL] [Abstract][Full Text] [Related]
31. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
[TBL] [Abstract][Full Text] [Related]
32. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
[TBL] [Abstract][Full Text] [Related]
33. The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature.
Pomero F; Ageno W; Serraino C; Borretta V; Gianni M; Fenoglio L; Prisco D; Dentali F
Thromb Res; 2014 Jul; 134(1):84-9. PubMed ID: 24837252
[TBL] [Abstract][Full Text] [Related]
34. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
[TBL] [Abstract][Full Text] [Related]
35. Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone.
Samama MM; Rached RA; Horellou MH; Aquilanti S; Mathieux VG; Plu-Bureau G; Elalamy I; Conard J
Br J Haematol; 2003 Oct; 123(2):327-34. PubMed ID: 14531916
[TBL] [Abstract][Full Text] [Related]
36. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
[TBL] [Abstract][Full Text] [Related]
37. The role of point mutations in the genes, predisposing inherited thrombophilia in the pathogeneses of proximal and distal deep vein thrombosis in Georgian population.
Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
Georgian Med News; 2014 Feb; (227):98-102. PubMed ID: 24632657
[TBL] [Abstract][Full Text] [Related]
38. Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.
Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
Georgian Med News; 2014 Feb; (227):93-7. PubMed ID: 24632656
[TBL] [Abstract][Full Text] [Related]
39. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
Kvasnicka J; Hájková J; Bobcíková P; Kvasnicka T; Dusková D; Poletínová S; Kieferová V
Cas Lek Cesk; 2012; 151(2):76-82. PubMed ID: 22515013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
